Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|July 3, 2018
Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinomaSilvia Ribback, Li Che, Maria G Pilo, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 7, 2016
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cellsDan Cao, Xinhua Song, Li Che, et al.Hepatology (Baltimore, Md.)|February 15, 2023
Aberrant fucosylation sustains the NOTCH and EGFR/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinomaCindy E Ament, Sara Steinmann, Katja Evert, et al.Oncotarget|September 15, 2017
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines <i>in vitro</i> and AKT-driven hepatocarcinogenesis in miceAntonio Cigliano, Chunmei Wang, Maria G Pilo, et al.Medicina (Kaunas, Lithuania)|July 27, 2024
Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27<sup>KIP1</sup> RegulationAntonio Cigliano, Maria M Simile, Gianpaolo Vidili, et al.Journal of Hepatology|May 30, 2021
Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activationXinhua Song, Hongwei Xu, Pan Wang, et al.Hepatology (Baltimore, Md.)|December 28, 2020
Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes-Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and HumansHaichuan Wang, Xinhua Song, Haotian Liao, et al.Oncotarget|December 7, 2017
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesisAntonio Cigliano, Maria G Pilo, Lei Li, et al.Journal of Experimental & Clinical Cancer Research : CR|September 6, 2024
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinomaAntonio Cigliano, Isabella Gigante, Marina Serra, et al.Journal of Experimental & Clinical Cancer Research : CR|June 2, 2022
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human diseaseAntonio Cigliano, Shanshan Zhang, Silvia Ribback, et al.Pageof 4